SCHEDULE: Randy Foong Discloses 9.12% Stake in China SXT Pharma
Beneficial Ownership Report
Randy Foong Soon Hong has disclosed a 9.12% beneficial ownership stake in China SXT Pharmaceuticals, Inc., holding over 10.5 million ordinary shares.
Summary
- Randy Foong Soon Hong, a Singaporean citizen, has filed a Schedule 13G indicating beneficial ownership in China SXT Pharmaceuticals, Inc.
- The filing reports ownership of 10,588,240 Ordinary Shares, which includes associated Warrants.
- This stake represents approximately 9.12% of the total voting power of China SXT Pharmaceuticals, Inc.
- The percentage is calculated based on 116,027,758 Ordinary Shares outstanding as of July 29, 2025, as provided by the Issuer.
- The total voting power of the Issuer is 116,053,826 votes, comprising 116,027,226 Class A Ordinary Shares (one vote each) and 532 Class B Ordinary Shares (fifty votes each).
- Mr. Foong Soon Hong holds sole voting and sole dispositive power over all 10,588,240 shares.
- The acquisition of these securities was not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a neutral, factual disclosure of beneficial ownership, not containing operational or financial performance data that would indicate positive or negative sentiment.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance or operations.
Industry Context
This filing indicates a significant individual investor's stake in a pharmaceutical company, which is a common occurrence in the public markets. Such disclosures provide transparency regarding major shareholders, which can be of interest to other investors assessing the company's ownership structure and potential influence.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant individual shareholder, which may influence perceptions of stability or potential future actions related to the company's control.
- Investment Professionals: Offers insight into the ownership structure and concentration, which is a key factor in investment analysis.
Key Dates
| Date | Description |
|---|---|
| 07/29/2025 | Date of event which requires the filing of this statement, and the date for which the outstanding share count was provided by the Issuer. |
| 08/07/2025 | Date the Schedule 13G statement was signed by Randy Foong Soon Hong. |
Keywords
China SXT Pharmaceuticals, SXT, Pharmaceuticals, Beneficial Ownership, Schedule 13G, Shareholder, Investment, Healthcare, Chinese Pharma
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.